Recent development on DNA & genome synthesis DOI
Wenfei Yu, Junbiao Dai, Yingxin Ma

et al.

Current Opinion in Systems Biology, Journal Year: 2023, Volume and Issue: 37, P. 100490 - 100490

Published: Nov. 23, 2023

Language: Английский

Targeted genome-modification tools and their advanced applications in crop breeding DOI
Boshu Li, Chao Sun, Jiayang Li

et al.

Nature Reviews Genetics, Journal Year: 2024, Volume and Issue: 25(9), P. 603 - 622

Published: April 24, 2024

Language: Английский

Citations

62

SYNTHETIC BIOLOGY AND ITS POTENTIAL IN U.S. MEDICAL THERAPEUTICS: A COMPREHENSIVE REVIEW: EXPLORING THE CUTTING-EDGE INTERSECTIONS OF BIOLOGY AND ENGINEERING IN DRUG DEVELOPMENT AND TREATMENTS DOI Creative Commons

Francisca Chibugo Udegbe,

Ogochukwu Roseline Ebulue,

Charles Chukwudalu Ebulue

et al.

Engineering Science & Technology Journal, Journal Year: 2024, Volume and Issue: 5(4), P. 1395 - 1414

Published: April 17, 2024

This study provides a comprehensive review of the cutting-edge intersections biology and engineering in realm medical therapeutics, focusing on advancements applications synthetic biology. The main objectives were to explore historical evolution, define scope, analyze current state-of-the-art biology, particularly drug development treatment strategies. methodology employed systematic literature content analysis, utilizing range academic databases gather relevant peer-reviewed articles published between 2013 2023. Key findings revealED that through integration principles biological systems, has led significant innovations therapeutics. These include novel delivery targeted therapies, personalized medicine approaches. highlights challenges limitations approaches, such as ethical concerns, regulatory hurdles, need for interdisciplinary collaboration. future landscape is marked by both prospects. field holds immense potential addressing complex diseases enhancing healthcare delivery, yet faces considerations frameworks. Strategic recommendations are provided researchers, industry leaders, policymakers, emphasizing continuous innovation, applications, Finally, stands transformative force with revolutionize healthcare. Future research should focus overcoming exploring new ensuring field's continued advancement contribution global healthcare. Keywords: Synthetic Biology, Medical Therapeutics, Drug Development, Bioengineering.

Language: Английский

Citations

26

The genomic route to tomato breeding: Past, present, and future DOI Creative Commons

Yan Wang,

Chuanlong Sun, Zhibiao Ye

et al.

PLANT PHYSIOLOGY, Journal Year: 2024, Volume and Issue: 195(4), P. 2500 - 2514

Published: April 30, 2024

Over the past 10,000 years, tomato species have undergone both unintentional and intentional selection to enhance their favorable traits for human consumption manufacturing. These processes significantly influenced genomes of played a critical role in improving varieties. In this review, we summarize recent advances genome sequencing, explore impact human-driven selection, recapitulate key genes associated with important agronomic breeding. We provide several examples genomics-guided breeding highlight potential resources facilitating improvement. Furthermore, elaborate progress strategies through design present how such efforts can help future enhancements align demands sustainability evolving societies.

Language: Английский

Citations

15

Exploiting synthetic biology platforms for enhanced biosynthesis of natural products in Yarrowia lipolytica DOI

Dahai Jiang,

Manqi Yang,

Kai Chen

et al.

Bioresource Technology, Journal Year: 2024, Volume and Issue: 399, P. 130614 - 130614

Published: March 19, 2024

Language: Английский

Citations

10

Efficient data reconstruction: The bottleneck of large-scale application of DNA storage DOI Creative Commons
Ben Cao, Yanfen Zheng, Qi Shao

et al.

Cell Reports, Journal Year: 2024, Volume and Issue: 43(4), P. 113699 - 113699

Published: March 21, 2024

Over the past decade, rapid development of DNA synthesis and sequencing technologies has enabled preliminary use molecules for digital data storage, overcoming capacity persistence bottlenecks silicon-based storage media. now been fully accomplished in laboratory through existing biotechnology, which again demonstrates viability carbon-based However, high cost latency reconstruction pose challenges that hinder practical implementation beyond laboratory. In this article, we review advanced methods, analyze characteristics performance biotechnological approaches at various stages writing reading, discuss potential factors influencing from perspective reconstruction.

Language: Английский

Citations

9

Enhancing glucaric acid production from myo -inositol in Escherichia coli by eliminating cell-to-cell variation DOI

Nana Ding,

Lei Sun, Xuan Zhou

et al.

Applied and Environmental Microbiology, Journal Year: 2024, Volume and Issue: 90(6)

Published: May 29, 2024

Glucaric acid (GA) is a value-added chemical and can be used to manufacture food additives, anticancer drugs, polymers. The non-genetic cell-to-cell variations in GA biosynthesis are naturally inherent, indicating the presence of both high- low-performance cells culture. Low-performance lead nutrient waste inefficient production. Furthermore,

Language: Английский

Citations

5

纳米材料助力合成生物学的生物医学应用 DOI
Lei Qi, Yifan Zhao,

Shuangyu Liu

et al.

Science China Materials, Journal Year: 2024, Volume and Issue: 67(7), P. 2051 - 2066

Published: May 22, 2024

Language: Английский

Citations

4

Building a eukaryotic chromosome arm by de novo design and synthesis DOI Creative Commons
Shuangying Jiang, Zhouqing Luo, Jie Wu

et al.

Nature Communications, Journal Year: 2023, Volume and Issue: 14(1)

Published: Nov. 30, 2023

The genome of an organism is inherited from its ancestor and continues to evolve over time, however, the extent which current version could be altered remains unknown. To probe plasticity Saccharomyces cerevisiae, here we replace native left arm chromosome XII (chrXIIL) with a linear artificial harboring small sets reconstructed genes. We find that as few 12 genes are sufficient for cell viability, whereas 25 required recover partial fitness defects observed in 12-gene strain. Next, demonstrate these can individually using synthetic regulatory sequences recoded open-reading frames "one-amino-acid-one-codon" strategy remain functional. Finally, neochromsome assembled substitute chrXIIL viability. Together, our work not only highlights high yeast genome, but also illustrates possibility making functional eukaryotic chromosomes entirely sequences.

Language: Английский

Citations

11

High plasticity of ribosomal DNA organization in budding yeast DOI Creative Commons
Shuangying Jiang, Zelin Cai, Yun Wang

et al.

Cell Reports, Journal Year: 2024, Volume and Issue: 43(2), P. 113742 - 113742

Published: Feb. 1, 2024

In eukaryotic genomes, rDNA generally resides as a highly repetitive and dynamic structure, making it difficult to study. Here, synthetic array on chromosome III in budding yeast was constructed serve the sole source of rRNA. Utilizing loxPsym site within each repeat Cre recombinase, we were able reduce copy number few eight copies. Additionally, strains with two or three arrays found that presence multiple did not affect formation single nucleolus. Although alteration position impact three-dimensional genome additional had no deleterious influence cell growth transcriptomes. Overall, this study sheds light high plasticity organization opens up opportunities for future engineering.

Language: Английский

Citations

4

Microbial cell factories for bioeconomy: From discovery to creation DOI Creative Commons
Xiongying Yan,

Qiaoning He,

Binan Geng

et al.

BioDesign Research, Journal Year: 2024, Volume and Issue: 6

Published: Jan. 1, 2024

Microbial cell factories (MCFs) are extensively used to produce a wide array of bioproducts, such as bioenergy, biochemical, food, nutrients, and pharmaceuticals, have been regarded the "chips" biomanufacturing that will fuel emerging bioeconomy era. Biotechnology advances led screening, investigation, engineering an increasing number microorganisms diverse MCFs, which workhorses help develop bioeconomy. This review briefly summarizes progress strategies in development robust efficient MCFs for sustainable economic biomanufacturing. First, comprehensive understanding microbial chassis cells, including accurate genome sequences corresponding annotations; metabolic regulatory networks governing substances, energy, physiology, information; their similarity uniqueness compared with those other microorganisms, is needed. Moreover, application effective tools crucial both model nonmodel cells into identification characterization biological parts, well design, synthesis, assembly, editing, regulation genes, circuits, pathways. also highlights necessity integrating automation artificial intelligence (AI) biotechnology facilitate future customized synthetic expedite industrialization process

Language: Английский

Citations

4